Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemotherapeutic Drug-Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions. | Curr Oncol Rep | 2025 | 41123838 | PubTator, text mining | PubMed |
| Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers. | Clin Cancer Res | 2025 | 41091103 | PubTator, text mining | PubMed |
| A novel folate receptor-targeted curcumin nano-delivery system: A dual therapeutic strategy for precise inhibition of MRCKβ to suppress ovarian cancer proliferation and immune escape. | Mater Today Bio | 2025 | 41080722 | PubTator, text mining | PubMed |
| Neurodevelopmental Impact of Maternal Immune Activation and Autoimmune Disorders, Environmental Toxicants and Folate Metabolism on Autism Spectrum Disorder. | Curr Issues Mol Biol | 2025 | 41020843 | PubTator, text mining | PubMed |
| Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K. | J Funct Biomater | 2025 | 41003423 | PubTator, text mining | PubMed |
| Rational design of the linkers in targeting chimeras. | Chem Sci | 2025 | 40988686 | PubTator, text mining | PubMed |
| Dual-receptor PET imaging of ovarian cancer using a 68Ga-labeled heterodimer targeting folate receptor and HER2. | Am J Nucl Med Mol Imaging | 2025 | 40980736 | PubTator, text mining | PubMed |
| Advance in therapies targeting tumor-associated macrophages in ovarian cancer. | Front Immunol | 2025 | 40963633 | PubTator, text mining | PubMed |
| Evaluating the anticancer properties of VAF: a novel folate-α-tocopherol conjugate against lung cancer cells. | BMC Cancer | 2025 | 40958098 | PubTator, text mining | PubMed |
| Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of Gynecologic Origin: The Updated College of American Pathologists Protocol. | Arch Pathol Lab Med | 2025 | 40956279 | PubTator, text mining | PubMed |
| Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer. | Oncol Ther | 2025 | 40952644 | PubTator, text mining | PubMed |
| Genetic background of neurological disorders with basal ganglia calcification. | J Neurol | 2025 | 40947452 | PubTator, text mining | PubMed |
| Transgenerational Effects and Heritability of Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorder. | Int J Mol Sci | 2025 | 40943215 | PubTator, text mining | PubMed |
| Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma. | Cancer Res Commun | 2025 | 40919994 | PubTator, text mining | PubMed |
| Mirvetuximab soravtansine in the ovarian cancer treatment landscape: influence of prior taxane exposure on outcomes. | Int J Gynecol Cancer | 2025 | 40916321 | PubTator, text mining | PubMed |
| The plasma proteome of plant-based diets: Analyses of 2920 proteins in 49,615 people. | Clin Nutr | 2025 | 40912079 | PubTator, text mining | PubMed |
| Cancer of the ovary, fallopian tube, and peritoneum: 2025 update. | Int J Gynaecol Obstet | 2025 | 40908761 | PubTator, text mining | PubMed |
| [Corneal events with mirvetuximab soravtansine : A review of ocular surface events associated with the tubulin-acting antibody-drug conjugate, mirvetuximab soravtansine]. | Ophthalmologie | 2025 | 40892244 | PubTator, text mining | PubMed |
| Current perspectives and global trends of nanotechnology in advanced breast cancer: a bibliometric and visualized analysis. | Discov Oncol | 2025 | 40879965 | PubTator, text mining | PubMed |
| Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre Study. | Int J Mol Sci | 2025 | 40869006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=11